Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
N Engl J Med
.
2020 Jan 2;382(1):91.
doi: 10.1056/NEJMc1915042.
Authors
Catherine R Rowan
1
,
Karen Boland
1
,
Gavin C Harewood
1
Affiliation
1
Beaumont Hospital, Dublin, Ireland catherinerowan@beaumont.ie.
PMID:
31875504
DOI:
10.1056/NEJMc1915042
No abstract available
Publication types
Letter
Comment
MeSH terms
Colitis, Ulcerative*
Humans
Induction Chemotherapy
Maintenance Chemotherapy
Ustekinumab*
Substances
Ustekinumab